Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$330,000.00
Apr 1, 2023
For-profit organization
Pre-Clinical Validation of a Bioabsorbable Flow-Diverting Stent for Bifurcation Aneurysms and Adjunctive Coiling
1007258
Intracranial aneurysms are classified as saccular or fusiform in shape, while the saccular type are further divided into sidewall and bifurcation aneurysms. While metal flow-diverting stents are increasingly being used to treat sidewall aneurysms, they have poor occlusion rates for fusiform and bifurcation types. The Fluid Biomed (FB) stent is a novel hybrid metal and bioabsorbable polymer flow diverter designed to treat sidewall, bifurcation, and fusiform aneurysms. Evaluating the effectiveness of the FB stent in sidewall aneurysms was successfully completed in previous IRAP funded projects. In the present application, we validate use of the FB stent in a pre-clinical in vitro and in vivo study on bifurcation and fusiform aneurysms.
$350,000.00
Jan 7, 2021
For-profit organization
000017828
000017828
Support for Fluid Biotech Inc. to continue operations during the COVID-19 pandemic